Onconetix Ownership 2024 | Who Owns Onconetix Now?

Overview ForecastFinancials Chart

Institutional Ownership

13.82%

Insider Ownership

17.69%

Retail Ownership

68.49%

Institutional Holders

21.00

Onconetix Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-56,400	-100.00%	-	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	-	-	-	-25,926	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-50,272	-100.00%	-	Mar 31, 2024
TWO SIGMA ADVISERS, LP	-	-	-	-10,000	-100.00%	-	Mar 31, 2024
O'DELL GROUP, LLC	-	-	-	-115	-100.00%	-	Mar 31, 2024

Onconetix's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-56,400	-100.00%	-	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	-	-	-	-25,926	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-50,272	-100.00%	-	Mar 31, 2024
TWO SIGMA ADVISERS, LP	-	-	-	-10,000	-100.00%	-	Mar 31, 2024
O'DELL GROUP, LLC	-	-	-	-115	-100.00%	-	Mar 31, 2024

The largest Onconetix shareholder by % of total assets is RENAISSANCE TECHNOLOGIES LLC. The company owns 0.00 shares of Onconetix (BWV), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
O'DELL GROUP, LLC	-	-	-	-115	-100.00%	-	Mar 31, 2024
TWO SIGMA ADVISERS, LP	-	-	-	-10,000	-100.00%	-	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	-	-	-	-25,926	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-50,272	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-56,400	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Onconetix's largest institutional buyer is O'DELL GROUP, LLC. The company purchased -0.12K stocks of BWV, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-56,400	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-50,272	-100.00%	-	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	-	-	-	-25,926	-100.00%	-	Mar 31, 2024
TWO SIGMA ADVISERS, LP	-	-	-	-10,000	-100.00%	-	Mar 31, 2024
O'DELL GROUP, LLC	-	-	-	-115	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Onconetix's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -56.40K shares of BWV, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-56,400	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-50,272	-100.00%	-	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	-	-	-	-25,926	-100.00%	-	Mar 31, 2024
TWO SIGMA ADVISERS, LP	-	-	-	-10,000	-100.00%	-	Mar 31, 2024
O'DELL GROUP, LLC	-	-	-	-115	-100.00%	-	Mar 31, 2024

Onconetix's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -56.40K shares, valued at -, as of undefined.

Onconetix Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	147,026	-48,461	-24.79%	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	52,400	-	-	Feb 29, 2024
iSHARES TRUST	0.00%	16,680	-	-	Feb 29, 2024

Onconetix's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 147.03K shares, compromising 0.00% of its total assets.

Onconetix Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	21	16.67%
30 Sep, 23	18	-
30 Jun, 23	18	38.46%
31 Mar, 23	13	-27.78%
31 Dec, 22	18	20.00%
30 Sep, 22	15	87.50%
30 Jun, 22	8	-38.46%
31 Mar, 22	13	-

As of 31 Dec 23, 21 institutions are holding Onconetix's shares, representing an increase of 16.67% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	2,421,823	-32.08%
30 Sep, 23	3,565,693	51.42%
30 Jun, 23	2,354,880	45.35%
31 Mar, 23	1,620,167	-16.32%
31 Dec, 22	1,936,159	-17.87%
30 Sep, 22	2,357,568	111.55%
30 Jun, 22	1,114,438	143.56%
31 Mar, 22	457,557	-

Onconetix (BWV) has 2.42M shares outstanding as of 31 Dec 23, down -32.08% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	13.82%	2.75%
30 Sep, 23	22.41%	10.23%
30 Jun, 23	14.80%	14.27%
31 Mar, 23	10.18%	4.09%
31 Dec, 22	15.78%	5.84%
30 Sep, 22	16.44%	19.05%
30 Jun, 22	9.29%	17.83%
31 Mar, 22	7.22%	-

As of 31 Dec 23, Onconetix is held by 13.82% institutional shareholders, representing a 2.75% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	7	-22.22%
30 Sep, 23	9	-35.71%
30 Jun, 23	14	100.00%
31 Mar, 23	7	-41.67%
31 Dec, 22	12	-7.69%
30 Sep, 22	13	85.71%
30 Jun, 22	7	-46.15%
31 Mar, 22	13	-

7 institutional shareholders have increased their position in BWV stock as of 31 Dec 23 compared to 9 in the previous quarter (a -22.22% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	4	33.33%
30 Sep, 23	3	-
30 Jun, 23	3	50.00%
31 Mar, 23	2	-50.00%
31 Dec, 22	4	100.00%
30 Sep, 22	2	-
30 Jun, 22	-	-
31 Mar, 22	-	-

4 institutional shareholders have reduced their position in BWV stock as of 31 Dec 23 compared to 3 in the previous quarter (a 33.33% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	21	16.67%	2,421,823	-32.08%	13.82%	2.75%	7	-22.22%	4	33.33%
30 Sep, 23	18	-	3,565,693	51.42%	22.41%	10.23%	9	-35.71%	3	-
30 Jun, 23	18	38.46%	2,354,880	45.35%	14.80%	14.27%	14	100.00%	3	50.00%
31 Mar, 23	13	-27.78%	1,620,167	-16.32%	10.18%	4.09%	7	-41.67%	2	-50.00%
31 Dec, 22	18	20.00%	1,936,159	-17.87%	15.78%	5.84%	12	-7.69%	4	100.00%
30 Sep, 22	15	87.50%	2,357,568	111.55%	16.44%	19.05%	13	85.71%	2	-
30 Jun, 22	8	-38.46%	1,114,438	143.56%	9.29%	17.83%	7	-46.15%	-	-
31 Mar, 22	13	-	457,557	-	7.22%	-	13	-	-	-

Onconetix Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 03, 2024	Schiess Ralph	officer	Chief Science Officer		Sell	-	-	-	269,749
Dec 28, 2023	Bruhlmann Christian	officer	Chief Strategy Officer		Sell	-	-	-	236,029
Oct 10, 2023	CAMPBELL NEIL J	director, officer	Chief Executive Officer		Sell	532,326	$0.43	$229.17K	-
Oct 10, 2023	Harmon Bruce	officer	Chief Financial Officer		Sell	177,442	$0.43	$76.39K	-
Apr 12, 2023	Cincinnati Cornerstone Investors BWV I, LLC	10 percent owner	-	J-Other	Sell	1,200,000	-	-	1,161,201
Nov 21, 2022	Cincinnati Cornerstone Investors BWV I, LLC	director	-	J-Other	Sell	750,000	-	-	2,361,201
Aug 29, 2022	Cincinnati Cornerstone Capital LLC	director		J-Other	Sell	500,000	-	-	3,111,201

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 03, 2024	Schiess Ralph	officer	Chief Science Officer		Sell	-	-	-	269,749
Dec 28, 2023	Bruhlmann Christian	officer	Chief Strategy Officer		Sell	-	-	-	236,029
Oct 10, 2023	CAMPBELL NEIL J	director, officer	Chief Executive Officer		Sell	532,326	$0.43	$229.17K	-
Oct 10, 2023	Harmon Bruce	officer	Chief Financial Officer		Sell	177,442	$0.43	$76.39K	-
Jun 01, 2023	Jeremic Vuk	director	-	A-Award	Buy	6,360	-	-	6,360
Jun 01, 2023	Ramdeen Timothy R.	director	-	A-Award	Buy	6,360	-	-	6,360
Jun 01, 2023	Tarsh Simon	director	-	A-Award	Buy	6,360	-	-	6,360
Jun 01, 2023	SAPIRSTEIN JAMES	director	-	A-Award	Buy	6,360	-	-	6,360
May 11, 2023	Hernandez Joseph	director, 10 percent owner, officer	CEO	A-Award	Buy	150,000	-	-	2,800,351
May 11, 2023	Garfield Jon	officer	Chief Financial Officer	A-Award	Buy	100,000	-	-	100,000
May 11, 2023	Henderson Erin	officer	Chief Business Officer	A-Award	Buy	150,000	-	-	174,752
Apr 12, 2023	Cincinnati Cornerstone Investors BWV I, LLC	10 percent owner	-	J-Other	Sell	1,200,000	-	-	1,161,201
Jan 30, 2023	Ramdeen Timothy R.	director	-	A-Award	Buy	2,386	-	-	2,386
Jan 17, 2023	Ramdeen Timothy R.	-	-		Buy	-	-	-	-
Jan 17, 2023	Ramdeen Timothy R.	director			Buy	-	-	-	-
Nov 21, 2022	Cincinnati Cornerstone Investors BWV I, LLC	director	-	J-Other	Sell	750,000	-	-	2,361,201
Nov 09, 2022	Jeremic Vuk	director	-	A-Award	Buy	3,610	-	-	3,610
Nov 08, 2022	Jeremic Vuk	-	-		Buy	-	-	-	-
Nov 08, 2022	Jeremic Vuk	director			Buy	-	-	-	-
Aug 29, 2022	Cincinnati Cornerstone Capital LLC	director		J-Other	Sell	500,000	-	-	3,111,201

The last insider sell of Onconetix's stock was made by Schiess Ralph on Jan 03 2024, selling - shares at - per share (valued at -).

Onconetix Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	7	1	700.00%
Q1 2023	1	-	-
Q4 2022	1	1	100.00%
Q3 2022	2	5	40.00%
Q2 2022	7	-	-
Q1 2022	1	6	16.67%

7 total buy trades, and 1 total sell trades (buy/sell ratio of 7.00%) were made by Onconetix's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	3	-
Q2 2022	-	-	-
Q1 2022	-	-	-

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Onconetix's stocks.

Onconetix Peer Ownership

Ticker	Company
CDIO	Cardio Diagnostics Holdings, Inc.
BDRX	Biodexa Pharmaceuticals Plc
VRAX	Virax Biolabs Group Limited
QNRX	Quoin Pharmaceuticals, Ltd.
PALI	Palisade Bio, Inc.
KPRX	Kiora Pharmaceuticals, Inc.
UNCY	Unicycive Therapeutics, Inc.
PXMD	PaxMedica, Inc. Common Stock
REVB	Revelation Biosciences, Inc.
HILS	Tharimmune, Inc.
ALLR	Allarity Therapeutics, Inc.

BWV Ownership FAQ

Who Owns Onconetix?

Onconetix is owned by institutional shareholders (13.82%), insiders (17.69%), and public (68.49%). The largest institutional shareholder of Onconetix is RENAISSANCE TECHNOLOGIES LLC (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Onconetix?

Onconetix's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, BANK OF NEW YORK MELLON CORP, CITADEL ADVISORS LLC, TWO SIGMA ADVISERS, LP, and O'DELL GROUP, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Onconetix shareholders are there?

As of Dec 2023, there are 21 institutional shareholders of Onconetix.

What percentage of Onconetix is owned by RENAISSANCE TECHNOLOGIES LLC?

RENAISSANCE TECHNOLOGIES LLC owns 0 shares of Onconetix, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).

What percentage of Onconetix is owned by BANK OF NEW YORK MELLON CORP?

As of Mar 2024, BANK OF NEW YORK MELLON CORP holds 0 shares of Onconetix (BWV), compromising 0% of the company, valued at $0.

What percentage of Onconetix is owned by CITADEL ADVISORS LLC?

CITADEL ADVISORS LLC is the third largest holder of Onconetix. The company owns 0 of the company's shares outstanding (worth $0).